Clinical Study on An Unani Formulation ‘Qurs e Kushta Khabs al-Hadeed and Habb-e-Marwareed’ in Sayalanal- Rahim (Leucorrhea)”
Najmus Sehar, Tasleem Ahmad, Mohd Wasim Ahmad, and Anirban Goswami
Hippocratic Journal of Unani Medicine
Hippocratic Journal of Unani Medicine April – June 2017, Vol. 12 No. 2, Pages 75-86
The objective of the study was to evaluate the safety and efficacy of Unani pharmacopoeial formulations viz. ‘Qurs e Kushta Khabs Al- Hadded and Habb-e-Marwareed’ in Sayalan-al-Rahim (Leucorrhea). One tablet of both drugs were administered orally to the patients, twice daily for 4 weeks. After the treatment, mean ± S.E.M. scores of clinical parameters of the disease including the amount of vaginal discharge, general weakness, backache, anaemia, excoriation and ulceration were subsided by 43.36% (p<0.001), 60.64% (p<0.001), 30.02% (p<0.001), 50.81% (p<0.001), 48.15% (p<0.001) and 44.26% (p<0.001) respectively as compared to the baseline. No adverse effect of the study drugs was found on the bio-chemical parameters of liver and Kidney function test. No adverse event was found either volunteered by the patients or elicited by the investigator by clinical as well as by laboratory investigations at the baseline and after the treatment. The Unani formulations Qurs e Kushta Khabs Al-Hadeed and Habb-e-Marwareed were found clinically very effective
and safe in the treatment of Sayalan-al-Rahim (Leucorrhea).